180 related articles for article (PubMed ID: 16955468)
1. Analysis of genetic abnormalities provides insights into genetic evolution of hyperdiploid myeloma.
Chng WJ; Ketterling RP; Fonseca R
Genes Chromosomes Cancer; 2006 Dec; 45(12):1111-20. PubMed ID: 16955468
[TBL] [Abstract][Full Text] [Related]
2. Chromosome abnormalities defined by conventional cytogenetics in plasma cell leukemia: what have we learned about its biology?
Jimenez-Zepeda VH; Neme-Yunes Y; Braggio E
Eur J Haematol; 2011 Jul; 87(1):20-7. PubMed ID: 21692850
[TBL] [Abstract][Full Text] [Related]
3. Chromosome aberrations in a series of 120 multiple myeloma cases with abnormal karyotypes.
Mohamed AN; Bentley G; Bonnett ML; Zonder J; Al-Katib A
Am J Hematol; 2007 Dec; 82(12):1080-7. PubMed ID: 17654686
[TBL] [Abstract][Full Text] [Related]
4. Dissecting karyotypic patterns in non-hyperdiploid multiple myeloma: an overview on the karyotypic evolution.
Jimenez-Zepeda VH; Braggio E; Fonseca R
Clin Lymphoma Myeloma Leuk; 2013 Oct; 13(5):552-8. PubMed ID: 23856591
[TBL] [Abstract][Full Text] [Related]
5. Further cytogenetic characterization of multiple myeloma confirms that 14q32 translocations are a very rare event in hyperdiploid cases.
Smadja NV; Leroux D; Soulier J; Dumont S; Arnould C; Taviaux S; Taillemite JL; Bastard C
Genes Chromosomes Cancer; 2003 Nov; 38(3):234-9. PubMed ID: 14506697
[TBL] [Abstract][Full Text] [Related]
6. Clonal evolution in t(14;18)-positive follicular lymphoma, evidence for multiple common pathways, and frequent parallel clonal evolution.
d'Amore F; Chan E; Iqbal J; Geng H; Young K; Xiao L; Hess MM; Sanger WG; Smith L; Wiuf C; Hagberg O; Fu K; Chan WC; Dave BJ
Clin Cancer Res; 2008 Nov; 14(22):7180-7. PubMed ID: 19010834
[TBL] [Abstract][Full Text] [Related]
7. Cytogenetics and molecular cytogenetics in multiple myeloma.
Liebisch P; Döhner H
Eur J Cancer; 2006 Jul; 42(11):1520-9. PubMed ID: 16781866
[TBL] [Abstract][Full Text] [Related]
8. Chromosome 1 abnormalities in multiple myeloma.
Marzin Y; Jamet D; Douet-Guilbert N; Morel F; Le Bris MJ; Morice P; Abgrall JF; Berthou C; De Braekeleer M
Anticancer Res; 2006; 26(2A):953-9. PubMed ID: 16619492
[TBL] [Abstract][Full Text] [Related]
9. Chromosomes in plasma-cell malignancies.
Van Den Berghe H
Eur J Haematol Suppl; 1989; 51():47-51. PubMed ID: 2697595
[TBL] [Abstract][Full Text] [Related]
10. Translocation t(11;14) in multiple myeloma: Analysis of translocation breakpoints on der(11) and der(14) chromosomes suggests complex molecular mechanisms of recombination.
Fenton JA; Pratt G; Rothwell DG; Rawstron AC; Morgan GJ
Genes Chromosomes Cancer; 2004 Feb; 39(2):151-5. PubMed ID: 14695995
[TBL] [Abstract][Full Text] [Related]
11. Chromosomal aberrations in 130 patients with multiple myeloma studied by interphase FISH: diagnostic and prognostic relevance.
Schmidt-Wolf IG; Glasmacher A; Hahn-Ast C; Jüttner A; Schnurr T; Cremer F; Moehler T; Goldschmidt H; Busert B; Schubert R; Schwanitz G
Cancer Genet Cytogenet; 2006 May; 167(1):20-5. PubMed ID: 16682281
[TBL] [Abstract][Full Text] [Related]
12. Molecular pathogenesis of multiple myeloma.
Tonon G
Hematol Oncol Clin North Am; 2007 Dec; 21(6):985-1006, vii. PubMed ID: 17996585
[TBL] [Abstract][Full Text] [Related]
13. Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma.
Debes-Marun CS; Dewald GW; Bryant S; Picken E; Santana-Dávila R; González-Paz N; Winkler JM; Kyle RA; Gertz MA; Witzig TE; Dispenzieri A; Lacy MQ; Rajkumar SV; Lust JA; Greipp PR; Fonseca R
Leukemia; 2003 Feb; 17(2):427-36. PubMed ID: 12592343
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of translational machinery and distinct genetic subgroups characterise hyperdiploidy in multiple myeloma.
Agnelli L; Fabris S; Bicciato S; Basso D; Baldini L; Morabito F; Verdelli D; Todoerti K; Lambertenghi-Deliliers G; Lombardi L; Neri A
Br J Haematol; 2007 Feb; 136(4):565-73. PubMed ID: 17367409
[TBL] [Abstract][Full Text] [Related]
15. Hyperdiploidy is a common finding in monoclonal gammopathy of undetermined significance and monosomy 13 is restricted to these hyperdiploid patients.
Brousseau M; Leleu X; Gerard J; Gastinne T; Godon A; Genevieve F; Dib M; Lai JL; Facon T; Zandecki M;
Clin Cancer Res; 2007 Oct; 13(20):6026-31. PubMed ID: 17947464
[TBL] [Abstract][Full Text] [Related]
16. Delineation of distinct subgroups of multiple myeloma and a model for clonal evolution based on interphase cytogenetics.
Cremer FW; Bila J; Buck I; Kartal M; Hose D; Ittrich C; Benner A; Raab MS; Theil AC; Moos M; Goldschmidt H; Bartram CR; Jauch A
Genes Chromosomes Cancer; 2005 Oct; 44(2):194-203. PubMed ID: 16001433
[TBL] [Abstract][Full Text] [Related]
17. Oligonucleotide-based array CGH as a diagnostic tool in multiple myeloma patients.
Smetana J; Fröhlich J; Vranová V; Mikulásová A; Kuglik P; Hájek R
Klin Onkol; 2011; 24 Suppl():S43-8. PubMed ID: 21923064
[TBL] [Abstract][Full Text] [Related]
18. A model for genetic complementation controlling the chromosomal abnormalities and loss of heterozygosity formation in cancer.
Nestor AL; Hollopeter SL; Matsui SI; Allison D
Cytogenet Genome Res; 2007; 116(4):235-47. PubMed ID: 17431320
[TBL] [Abstract][Full Text] [Related]
19. Genetics of multiple myeloma.
Higgins MJ; Fonseca R
Best Pract Res Clin Haematol; 2005; 18(4):525-36. PubMed ID: 16026735
[TBL] [Abstract][Full Text] [Related]
20. Chromosomal abnormalities of adenocarcinoma of the pancreas: identifying early and late changes.
Kowalski J; Morsberger LA; Blackford A; Hawkins A; Yeo CJ; Hruban RH; Griffin CA
Cancer Genet Cytogenet; 2007 Oct; 178(1):26-35. PubMed ID: 17889705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
